ArticlePDF Available

The effects of whole-body-vibration exercises in Parkinsons disease: a short review

Authors:

Abstract and Figures

Parkinson's disease (PD) is a complex, progressive and disabling neurodegenerative disorder marked by progressive loss of nigrostriatal dopaminergic neurons which is related to a continuous impairment of motor functions. As pharmacological treatments (L-Dopa, Dopamin Agonists) are lowly effective with respect to postural disturbance, and furthermore they lose effectiveness with disease progression potent nonpharmacologic therapies, are of crucial importance for the management of impairments. Besides traditional types of exercise, like strength or endurance training, whole body vibration was found having positive influence on PD motor symptoms. The aim of this work is to present a suitable review about the published papers found in the PubMed in which there are information about the use of the whole body vibration in patients with PD. Using the keywords "Parkinson's disease" or "Parkinson's disease" associated with "whole body vibration" six publications were found. One publication among the six, it was about vibration delivered in the entire body produced by a physioacoustic chair and it was also not analyzed in this work. Five papers among six were selected after a search in the PubMed using the keywords "Parkinson´s disease" and "whole body vibration". The frequency used in four of these five papers is the same (6Hz). Only a paper presents a frequency of 25Hz. The positive findings indicated in the papers seem in depend on the frequency and they were found with 6 or 25 Hz. Only in a publication has not presented difference between the clinical conditions in the experimental (whole body vibration) and control (placebo). All the other authors have noticed positive clinical findings using the oscillating platform. It is highly relevant in the development of clinical procedures to the management of patients with PD. As the use of the oscillating platforms is very inexpensive and positive clinical findings have been noticed with the use of whole body vibration in patients with PD, it is suggested to implement the studies involving the application of the exercises with whole body vibration in oscillating platforms to manage the patients with PD.
Content may be subject to copyright.
Journal of Medicine and Medical Science Vol. 2(1) pp. 594-600 January 2010
Available online@http://www.interesjournals.org/JMMS
Copyright ©2011 International Research Journals
Review
The effects of whole-body-vibration exercises in
Parkinson´s disease: a short review
Nelson S. Pinto1, Milena B. Monteiro2, Patricia Froes Meyer3, Sebastião D. Santos-Filho1,
Fabiana Azevedo-Santos1, Raquel M. Bernardo1, Dulciane Paiva4, Daiane Thompson5, Sotiris
Missailidis6, Pedro J. Marín7,8, Christian T. Haas9, Mario Bernardo-Filho1,10
1Universidade do Estado do Rio de Janeiro, Instituto de Biologia Roberto Alcantara Gomes, Departamento de Biofísica
e Biometria, Rio de Janeiro, RJ, Brazil.
2Clínica de Fisioterapia e Biomedicina, Rio de Janeiro, RJ, Brazil.
3Universidade Potiguar, Natal, RN.
4Universidade Santa Cruz do Sul, RS, Brasil.
5The Queen's Medical Center, Cancer Center Program Medical Director, Women's Health Center, Honolulu, HI, USA.
6The Open University, UK.
7Laboratory of Physiology, European University Miguel de Cervantes, Valladolid, Spain.
8Research Center on Physical Disability, ASPAYM, Castilla y León, Spain.
9University of Applied Sciences, Idstein, Germany.
10Coordenadoria de Pesquisa, Instituto Nacional do Câncer, INCa, Rio de Janeiro, RJ, Brazil.
Accepted 17 January, 2011
Parkinson’s disease (PD) is a complex, progressive and disabling neurodegenerative disorder marked
by progressive loss of nigrostriatal dopaminergic neurons which is related to a continuous impairment
of motor functions. As pharmacological treatments (L-Dopa, Dopamin Agonists) are lowly effective with
respect to postural disturbance, and furthermore they lose effectiveness with disease progression
potent nonpharmacologic therapies, are of crucial importance for the management of impairments.
Besides traditional types of exercise, like strength or endurance training, whole body vibration was
found having positive influence on PD motor symptoms. The aim of this work is to present a suitable
review about the published papers found in the PubMed in which there are information about the use of
the whole body vibration in patients with PD. Using the keywords “Parkinson’s disease” or
“Parkinson’s disease” associated with “whole body vibration” six publications were found. One
publication among the six, it was about vibration delivered in the entire body produced by a
physioacoustic chair and it was also not analyzed in this work. Five papers among six were selected
after a search in the PubMed using the keywords “Parkinson´s disease” and “whole body vibration”.
The frequency used in four of these five papers is the same (6Hz). Only a paper presents a frequency of
25Hz. The positive findings indicated in the papers seem in depend on the frequency and they were
found with 6 or 25 Hz. Only in a publication has not presented difference between the clinical conditions
in the experimental (whole body vibration) and control (placebo). All the other authors have noticed
positive clinical findings using the oscillating platform. It is highly relevant in the development of
clinical procedures to the management of patients with PD. As the use of the oscillating platforms is
very inexpensive and positive clinical findings have been noticed with the use of whole body vibration
in patients with PD, it is suggested to implement the studies involving the application of the exercises
with whole body vibration in oscillating platforms to manage the patients with PD.
Keywords: Parkinson’s disease; Whole body vibration, PubMed, review.
Pinto et al 595
INTRODUCTION
Parkinson’s disease (PD) is a complex, progressive and
disabling neurodegenerative disorder marked by
progressive loss of nigrostriatal dopaminergic neurons
leading to loss of motor functions (Hirsch and Farley,
2009; Diaz and Waters, 2009). Moreover, it affects over
one million people in the USA and an estimated five
million people in the world (Strickland and Bertoni, 2004;
de Lau LM and Breteler, 2006; Pahwa and Lyons, 2010).
PD is comprised of motor and non-motor signs and
symptoms (Chen, 2010). The clinical course of PD often
starts with non-motor symptoms, as gastrointestinal
disturbances (constipation), hyposmia and rapid eye
movement sleep behavior disorder. Patients are normally
not diagnosed at this stage of the disease. The diagnosis
occur when they exhibit clear and obvious motor
symptoms, as retting tremor, rigidity, impaired postural
reflexes and/or bradykinesia. At a larger stage with the
progress of the disease, they present disability due to
bradykinesia, rigidity, gait and balance difficulty, and falls
(Diaz and Waters, 2009; Chen, 2010). In addition,
dopaminergic-related side effects from medications like
dykineasia become more problematic. In more advanced
stages of the disease, disabling cognitive symptoms, as
dementias, are more common (Chen, 2010).
Furthermore, the more the disease proceeds, the lower is
effectiveness and efficiency of pharmaceutical
interventions. Especially, postural and gait disorders
become stronger and more frequent and L-dopa
administration is lowly effective to treat these symptoms.
This is - among other things - of crucial importance since
mobility deficits like gait impairment, postural instability,
and history are of highest concern for the quality of life in
PD (Schrag et al., 2000). Moreover, maintaining a critical
level of mobility is necessary in order to avoid, nursing at
home, loosing independence and social contacts.
The cause of PD remains unknown and no cure or
prevention exists so far and this disease primarily affects
people over the age of 50 years old, and the prevalence
and incidence increase with age. In consequence, the
aging of the general population in the world will result in a
dramatic number of people diagnosed with PD (Dorsey et
al., 2007). The incidence of the disease rises steeply with
age, from 17·4 in 100 000 person years between 50 and
59 years of age to 93·1 in 100 000 person years between
70 and 79 years, with a lifetime risk of developing the
*Corresponding author E-mail: santos-filho@uerj.br and
sdsfilho@terra.com.br
disease of 1·5% (de Rijk et al., 1995; Bower et al., 1999;
Lees et al., 2009).
Pharmacologic and nonpharmacologic interventions
are suggested being able to treat the symptoms of the
patients with PD (Hirsch and Farley, 2009; Pahwa and
Lyons, 2010).
The most potent for efficacy therapeutic for symptoms
of the PD is levodopa, which is converted to dopamine
through decarboxylation (Olanow et al., 2009). But its use
has been implicated in the development of motor
complications (wearing "off" and dyskinesias). Evidence
from preclinical studies suggests that these complications
are related to pulsatile stimulation of the striatal
dopamine receptors due to multiple orally administered
levodopa intake (Klivenyi and Vecsei, 2010).
Furthermore, levodopa is lowly effective to treat postural
disturbances and gait disorders or it might even worsen
these symptoms (Bronte-Stewart et al., 2002;
O'Suilleabhain et al., 2001). However, these symptoms
are of highest concern for the quality of life in PD (Schrag
et al., 2000; Karlsen et al., 2000).
Nonpharmacologic therapies are widely recommended
for the management of impairments that are not
responsive to pharmacologic treatment (Ebersbach et al.,
2008). Furthermore, Hirsch and Farley, 2009 consider the
importance of the exercises, as a non-pharmacological
approach, to management of people living with PD.
The effects of vibratory stimulation in PD were first
described by the neurophysiologist Jean Marie Charcot in
the 19th century. He found that PD patients show less
symptoms when they were travelling with the train and he
concluded in a further step that these effects result
vibratory stimuli that were generated by the train.
Nowadays various vibrating platforms are available that
are used for exercise and therapeutic reasons. However,
the frequencies and the amplitudes of the generated
vibratory stimuli vary whereby different physiological
reactions occur (Haas, 2008). Furthermore different
effects can result from the number of trainings sets and
its duration and well as the time to rest intervals, etc. All
these conditions depend on, mainly, the clinical and
physical conditions of the patient (Cardinale and
Wakeling, 2005).
The effects of the whole body vibration are probably
related to direct and indirect actions (Santos-Filho et al.,
2010). Obviously the best analyzed effect of vibratory
stimuli is a reflectory neuromuscular activity known as
“tonic-vibration-reflex” (TVR). This phenomenon was
firstly described in 1966 Matthews (Matthews, 1996) as
well as by Hagbarth and Eklund (Hagbarth KE and
596 J. Med. Med. Sci.
Table 1. Number of publications found in the PubMed involving Parkinson´s disease and whole body vibration.
Search Number of publications
Parkinson 49415
“Parkinson’s disease” 35776
“Parkinson’s disease” and “whole body vibration” 7
“Parkinson’s disease” and “whole body vibration exercises” 2
“Parkinson disease 40355
“Parkinson disease” and “whole body vibration” 6
“whole body vibration” 628
Eklund, 1966). From a functional point of view, the TVR is
characterized by a transfer of vibrations to the muscular
tendon system which is accompanied by repetitive
muscle spindle stretches which leads in a further step to
reflex answers. However, further studies showed that this
TVR varied in strength from one subject to the next which
might also explain a huge effect variety on different
physiological levels. For instance besides direct effects
on the neuromuscular level (Torvinen et al., 2002)
reactions occur also within the neuroendocrine system
(Prisby et al., 2008).
Other authors have demonstrated that whole body
vibration exercises might improve muscle strength (Rees
et al., 2008) bone density (Rubin et al., 2003;
Verschueren et al., 2004), postural control (Rees et al.,
2009) and muscle power (Russo et al., 2003). Moreover,
the health-related quality of life is increased and the fall
risk is decreased (Bruyere et al., 2005). Improvement of
gait and balance with WBV has been shown in a
population of nursing home residents (Bruyere et al.,
2005). The exercises produced by these vibrations in the
human body have also been used successfully to treat
patients with some diseases related to the impairments
involving the central nervous system, as cerebral palsy
(Semler et al., 2007), multiple sclerosis (Schuhfried et al.,
2005), spinal cord injury (Ness and Field-Fote, 2009) and
stroke (Nes et al., 2004). Some studies considered also
the effects of whole body vibrations on motor symptoms
in PD (Ebersbach et al., 2008; Turbanski et al., 2005;
Haas et al., 2006a; Haas et al., 2006b).
Putting together the findings reported in the literature,
investigations about the effectiveness of the action of the
vibration produced in oscillating platforms that is a low
cost physiologic strategy to treat PD would be welcome.
PubMed is a service of the United States National Library
of Medicine of the National Institutes of Health
(http://www.ncbi.nlm.nih.gov/PubMed/). PubMed is a
databank that comprises more than 19 million citations
for biomedical articles from MEDLINE and life science
journals. These citations may include links to full-text
articles from PubMed Central or publisher web sites.
Moreover, these citations have been used as tool to
obtain various scientific informations (Santos-Filho et al.,
2004, Fontenelle et al., 2009).
To our knowledge, no previous systematic revisions
have been published and indexed in the PubMed
involving only whole body vibration and Parkinson´s
disease. The aim of this work is to present a suitable
review about the published papers found in the PubMed
databank in which there are information about the use of
the whole body vibration in the management of patients
with Parkinson´s disease.
MATERIALS AND METHODS
Strategy for PubMed search
The papers were searched in the PubMed on April 21st
2010. The search was performed using the keywords (i)
Parkinson (ii) “Parkinson’s disease” (iii) “Parkinson’s
disease” and “whole body vibration”, (iv) “Parkinson’s
disease” and “whole body vibration exercises”, (v)
“Parkinson disease”, (vi) “Parkinson disease” and whole
body vibration” and (vii) “whole body vibration”.
The number of publications (NP) was determined using
the strategy above.
The selected publications concerning to the use of
“whole body vibration” and Parkinson’s disease and
published in English, they were read and considered to
be discussed in this work.
RESULTS
Table 1 above shows the number of publications
involving PD and whole body vibration. The keyword
“Parkinson” has a strong number of citations; however,
Pinto et al 597
Table 2. Information about the device of the oscillating platform, the subjects, the frequency and the amplitude used in the
oscillating platforms
Reference Device of the platform Number of subjects/sex/age Frequency Amplitude
Turbanski
et al, 2005
Zeptor med System, Fa.
Scisens, Germany
52 patients (38 male and 14 female,
69.1±8.9 years divided in control
group and experimental group (whole
body vibration)
6±1 Hz 3mm
Haas et al,
2006a
Zeptor med System, Fa.
Scisens, Germany
63 patients (53 male and 15 female,
65.0±7.8 years divided in control
group and experimental (whole body
vibration) group)
6±1 Hz 3mm
Haas et al,
2006b
Srt-medical system
(human mobility,
Germany
28 patients (63.1±7.3 years divided in
control group and experimental
(whole body vibration) group)
6±1 Hz No informed
Ebersbach
et et al,
2008
Galileo device,
Germany
Control group (7 men/4women,
75.0±6.8 years) and treated group (7
men/3women, 72.5±6.0 years)
25Hz 7 to 14 mm
Arias et al,
2009
Fit Massage, PYC
Fitness International,
Inc.
Control group (6 men/5women,
66.0±5.57 years) and treated group
(6 men/4women, 66.90.5±11.11
years)
6 Hz No informed
an important number of them are also considering the
name of the author in the publications.
The search performed also with the keywords
“Parkinson’s disease” and “Parkinson disease” has
shown 35776 and 40355 publications, respectively. Both
searches performed with the keywords “Parkinson’s
disease” or “Parkinson disease” associated with “whole
body vibration” has shown the same six publications.
However, with the search involving “Parkinson’s disease”
and whole body vibration” an additional reference was
found. As it is written in Russian, this citation was not
considered in this work. Moreover, one publication (King
et al., 2009) among the six, it was about vibration
delivered in the entire body produced by a physioacoustic
chair and it was also in Table 2 and 3. Table 2 shows
information about the device of the oscillating not
analysed in this work. An important number of
publications related with whole body vibration were
found.
The five selected publications found with "whole body
vibration" and Parkinson’s disease were analyzed
platform, the subjects (number, sex and age), the
frequency and the amplitude used in the oscillating
platforms.
Table 3 shows information about the conditions of
protocols used in the treated and control groups, as well
as the clinical findings.
DISCUSSION
The search strategy regarding studies which analyzed
the effects of WBV in PD can be seen in the Table 1. It
seems necessary to discuss the type search strategy
which led to the results. There are differences in the
number of publications, if it is searched “Parkinson’s
disease” or “Parkinson disease”. Moreover, if the
keyword “Parkinson” is used in the search, it is necessary
to see carefully the results. In this case, publications,
considering the name of the author “Parkinson” will
appear.
Pharmacologic treatments to manage symptoms of the
patients with PD have been suggested (Hirsch and
Farley, 2009; Pahwa and Lyons, 2010). However, side
effects from these medications have been reported
(Chen, 2010). Moreover, some impairment related to the
PD is not responsive to the pharmacologic treatment
(Bloem et al., 1996; Pinto et al., 2004). In consequence,
the use of alternative treatment strategies, e.g. as
different types of exercises, in patients with PD is
desirable and welcomes (Hirsch and Farley, 2009).
Some authors have utilized the whole body vibration
produced to manage some symptoms in patients with PD
(Ebersbach et al., 2008; Turbanski et al., 2005; Haas et
al., 2006a; Haas et al., 2006b; Arias et al., 2009). Five
papers among six were selected after a search in the
598 J. Med. Med. Sci.
Table 3. Information about the conditions of protocols used in the treated and control groups and the clinical findings
Reference Condition of the treated and control
groups
Clinical finding
Turbanski et
al, 2005
Treated group (5 series lasting 60
seconds)
Whole body vibration improved postural stability in
Parkinson´s disease spontaneously.
Haas et al,
2006a
Treated group (5 series lasting 60
seconds)
A highly significant imporvement of 16.8% in the
Unified Parkinson´s Disease Rating Scale motor
score was found in the treated group. Tremor and
rigidity scores were improve by25 and 24%,
respectively.
Haas et al,
2006b
Treated group (5 series lasting 60
seconds)
Proprioceptive performance was analyzed using a
tracking task basing on knee extension and flexion
movements. No significant differences became
evident between experimental and control group. The
authors consider that spontaneous improvements in
postural control are not directly connected with
proprioceptive changes.
Ebersbach et
et al, 2008
Control group (conventional balance
training including exercises on a tilt
board), Treated group (whole body
vibration on an oscillating platform).
Patients received 30 sessions (two
15min sessions a day, 5 day a week)
Quantitative dynamic posturography only improved in
patients with WBV whereas there was no significant
change in controls.
Arias et al,
2009
Control group (same conditions of the
treated group, however vibration was
not applied exercises on a tilt board),
Treated group (whole body vibration on
an oscillating platform).
Patients received 12 stimulations (5
sets of stimulation of 1 min each, with
an interset rest period of 1 min) over 5
weeks, on non consecutive days
No difference between the clinical conditions in the
experimental (whole body vibration) and control
(placebo) was found.
Pubmed using the keywords “Parkinson´s disease” and
“whole body vibration”. The scientific information about
these papers is shown in the Table 2 and Table 3. The
frequency used in four of these five papers is the same (6
Hz). Only one paper presents a frequency of 25Hz. The
positive findings indicated in the papers seem in depend
on the frequency and they were found with 6 or 25Hz
(Table 2).
Only Arias et al., 2009 have not found difference
between the clinical conditions in the experimental (whole
body vibration) and control (placebo). All the other
authors have noticed some positive clinical findings using
the oscillating platform (Table 3).
Ebersbach et al., 2008 have concluded that the
postural control and the gait improved in patients with PD
receiving whole body vibration or conventional
physiotherapy in the setting of a comprehensive
rehabilitation program. Although, the positive findings
obtained by these authors, they suggest that there was
no conclusive evidence for superior efficacy of WBV
compared with conventional balance training.
Firstly, Haas et al (2006a) found a randomized
controlled trial significant improvement in the Unified PD
Rating Scale motor score in the treated group (~15%). In
subcomponents (tremor, rigidity) improvements of 25 and
24% respectively became evident. However no changes
could be identified in facial expression or speech. Haas et
al (2006b) have tried to justify the findings reported by
Haas et al (2006a) as due proprioceptive changes
induced by the whole body vibrations. Proprioceptive
performance was analyzed using a tracking task basing
on knee extension and flexion movements. Treatment
consisted of 5 series of random whole-body vibration
taking 60 seconds each. Prominent over- and
undershooting errors were found in both groups (with or
without whole body vibration) representing proprioceptive
impairments. No significant differences became evident,
however, either between pre- and post-tests or between
experimental and control group. These authors
concluded that (i) spontaneous improvements in postural
control are not directly connected with proprioceptive
changes and (ii) nevertheless, one also should keep in
mind the general aspects and difficulties of analyzing
proprioception.
Chen (2010) and O´Brien et al (2009) have reported
that, overall, the annual economic impact of PD in the
United States is estimated at $10.8 billion, 58% of which
is related to direct medical costs. As the clinical use of
the oscillating platforms is very inexpensive, the whole
body vibration could be an excellent alternative to treat
the patients with PD. In this case, further investigations
must be stimulated to provide a suitable and safe clinical
procedure, besides a better understanding of the
biological mechanisms involved in the improving of the
motor symptoms of the PD patient that are under
treatment in an oscillatory platform.
CONCLUSION
Whole body vibration exercises is highly relevant in the
development of clinical procedures to the management of
patients with PD. As (i) the use of the oscillating platforms
is very inexpensive (Alentorn-Geli et al, 2008) and (ii)
positive clinical findings have been noticed with the use
of whole body vibration in patients with PD, it is
suggested to implement the studies involving the
application of the exercises with whole body vibration in
oscillating platforms to manage the patients with PD.
ACKNOWLEDGEMENTS
This work was supported by CNPq, FAPERJ, UERJ and
INCa.
REFERENCES
Arias P, Chouza M, Vivas J, Cudeiro J (2009). Effect of whole body
vibration in Parkinson's disease: a controlled study. Mov. Disord.
24:891-898.
Bloem BR, Beckley DJ, van Dijk JG, Zwinderman AH, Remler MP, Roos
RAC (1996). Influence of dopaminergic medication on automatic
postural responses and balance impairment in Parkinson's disease.
Mov. Disord. 11:509–521
Bower JH, Maraganore DM, McDonnell SDK, Rocca W A (1999).
Incidence and distribution of parkinsonism in Olmsted County,
Minnesota, 1976–1990. N eurol. 52: 1214–1220.
Bronte-Stewart HM, Minn AY, Rodrigues K, Buckley EL, Nashner LM
(2002). Postural instability in idiopathic Parkinson’s disease: the role
of medication and unilateral pallidotomy. Brain. 125: 2100-2114.-
O'Suilleabhain P, Bullard J, Dewey RB (2001). Proprioception in
Parkinson's disease is acutely depressed by dopaminergic
medications. J. Neurol. Neurosurg. Psychiatr. 71:607-610
Bruyere O, Wuidart MA, Di Palma E, Gourlay M, Ethgen O, Richy F,
Reginster JY (2005). Controlled whole body vibration to decrease fall
risk and improve health-related quality of life of nursing home
residents. Arch. Phys. Med. Rehabil. 86:303-307.
Cardinale M, Wakeling J (2005) Whole body vibration exercises: are
vibrations good for you? Br. J. Sports Med. 39:585-589
Pinto et al 599
Chen JJ (2010). Parkinson´s disease: health-related quality of life,
economic cost, and implications of early treatment. A m. J. Manage.
Care. 16:S87-S93, 2010
de Lau LM, Breteler MM (2006). Epidemiology of Prkinson´s disease.
Lancet Neurol 5: 525-535, 2006
de Rijk MC, Breteler MM, Graveland GA, Ott A, Grobbee DE, van der
Meché FG, Hofman A (1995). Prevalence of Parkinson’s disease in
the elderly: the Rotterdam Study. Neurol. 45: 2143–2146.
Diaz NL, Waters CH (2009). Current strategies in the treatment of
Parkinson´s disease and a personalized approach to management.
Expert Rev. Neurother. 9:1781-1789
Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG,
Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner
CM (2007). Projected number of people wit Parkinsons´s disease in
the most populous nations, 2005 through 2030. Neurol. 68:384-386
Ebersbach G, Edler D, Kaufhold O, W issel J (2008). W hole body
vibration versus conventional physiotherapy to improve balance and
gait in Parkinson's disease. Arch. Phys. Med. Rehabil. 89:399-403.
Fontenelle LF, Harrison BJ, Yücel M, Pujol J, Fujiwara H, Pantelis C
(2009). Is There Evidence of Brain White-Matter Abnormalities in
Obsessive-Compulsive Disorder?: A Narrative Review. Top Magn
Reson Imaging. 20:291-298.
Haas CT (2008). Vibratory Stimulation and Stochastic Resonance
Therapy: Results from studies in Parkinson’s disease and spinal cord
injury. Technologies of Globalization Congress Darmstadt, Germany,
2008
Haas CT, Buhlmann A, Turbanski S, Schmidtbleicher D (2006b).
Proprioceptive and s ensorimotor performance in Parkinson's disease.
Res. Sports Med. 14:273-287.
Haas CT, Turbanski S, Kessler K, Schmidtbleicher D (2006a). The
effects of random whole-body-vibration on motor symptoms in
Parkinson's disease. NeuroRehabil. 21:29-36.
Hagbarth KE, Eklund G (1966). Motor eff ects of vibratory muscle stimuli
in man, in Proceedings of the First N obel Symposium, Edited by R.
Granit. Almqvist and W iksell, Stockholm. Pp. 177-186.
Hirsch MA, Farley BG (2009). Exercise and neuroplasticity in persons
living with Parkinson´s disease. Eur. J. Phys. Rehabil. Med. 45:215-
229.
Karlsen KH, Tandberg E, Arsland D, Larsen JP (2000). Health related
quality of life in Parkinson’s disease: a prospective longitudinal study.
J. Neurol. Neurosurg. Psychiatr. 69: 584-589.
King LK, Almeida QJ, Ahonen H (2009). Short-term effects of vibration
therapy on motor impairments in Parkinson's disease. NeuroRehabil.
25:297-306.
Klivenyi P and Vecsei L (2010). Novel therapeutic strategies in
Parkinson’s disease. Eur. J. Clin. Pharmacol. 66:119–125.
Lees AJ, Hardy J, Revesz T (2009). Parkinson´s disease. Lancet 373:
2055–2066.
Matthews PBC (1966). The reflex excitation of the soleus muscle of the
decerebrate c at caused by vibration applied to its tendon. J. Physiol.
184:450-472.
Nes van IJW, Geurts ACH, Hendricks HT, Duysens J (2004). Short-term
effects of whole body vibration on postural control in unilateral
chronic stroke patients: preliminary evidence. Am. J. Phys. Med.
Rehabil. 83: 867–873
Ness LL, Field-Fote EC (2009). W hole-body vibration improves walking
function in individuals with spinal cord injury: a pilot study. Gait
Posture. 30:436-440.
O’Brien JA, W ard A, Michels SL, Tzivelekis S, Brandt NJ (2009).
Economic burden associated with Parkinson disease. Drug Benefit
Trends. 21:179-190.
Olanow CW, Rascol O, Hauser R Feigin PD, Jankovic J, Lang A,
Langston W, Melamed E, Poewe W , Stocchi F, Tolosa E; ADAGIO
Study Investigators (2009). A double-blind, delayed-start trial of
rasagiline in Parkinson´s disease. N. Engl. J. Med. 361:1268-1278.
Pahwa R and Lyons KE (2010). Early diagnosis of Parkinson´s disease:
recommendations from diagnostic clinical guidelines. Am. J. Manage.
Care. 16:S94-S99.
600 J. Med. Med. Sci.
Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou
P (2004). Treatments for dysarthria in Parkinson's disease. Lancet
Neurol. 3:547-556
Prisby RD, Lafage-Proust M, Malaval L, Belli A, Vico L (2008). Effects of
whole body vibration on the skeleton and other organ systems in man
and animal models: what we know and what we need to know.
Ageing Res. Rev. 7:319-329.
PubMed (2010). U.S. National Library of Medicine, National Institute of
Health, http://www.ncbi.nlm.nih.gov/PubMed/ (accessed on April 3rd,
2010).
Rees SS, Murphy A J and W atsford M L (2009). Effects of whole body
vibration on postural steadiness in an older population. J. Sci. Med.
Sport. 12:440–444
Rees SS, Murphy AJ, W atsford ML (2008). Effects of whole body
vibrationexercise on lower-extremity muscle strength and power in an
older population: a randomized clinical trial. Phys. Ther. 88:462-470.
Rubin, C, Recker R, Cullen D, Ryaby J, Mccabe J, Mcleod K (2003).
Prevention of postmenopausal bone loss by a low-magnitude,
highfrequency mechanical stimuli: a clinical trial assessing
compliance, efficacy, and safety. J. Bone Miner. Res. 19: 343–351.
Russo CR, Lauretani F, Bandinelli S, Bartali B, Cavazzini C, Guralnik
JM, Ferrucci, A (2003). High-frequency vibration training increases
muscle power in postmenopausal women. Arch. Phys. Med. Rehabil.
84:1854–1857
Santos-Filho SD, Bastos SRC, Pereira FAO, Senna-Fernandes V,
França D, Guilhon S, Bernardo-Filho M (2004). Traditional medicine:
an evaluation of the interest of the publication of scientific papers
about moxibustion. J. Med. Sci. 4:59-62.
Santos-Filho SD, Meyer PF, Ronzio OA, Bonelli L, Fonseca AS,
Bernardo-Filho M (2010). Whole body vibration exercise: what do you
know about scientific interest? Fiep Bull. 80:875-878.
Schrag A, Jahanshahi M, Quinn N (2000). W hat contributes to quality of
life in patients with Parkinson's disease? J. Neurol. Neurosurg.
Psychiatr. 69:308-312
Schuhfried O , Mittermaier C, Jovanovic T, Pieber K, Paternostro-Sluga
T (2005) Effects of whole body vibration in patients with multiple
sclerosis: a pilot study. Clin. Rehabil. 19: 834-842
Semler O, Fricke O, Vezyroglou K, Stark C, Schoenau E (2007).
Preliminary results on the mobility after whole body vibration in
immobilized children and adolescents. J. Musculoskele.t Neuronal
Interact. 7:77-781
Strickland D, Bertoni JM (2004). Parkinson´s prevalence estimated by a
state registry. Mov. Disord. 19:318-323
Torvinen S, Sievanen H, Jarvinen TA, Pasanen M, Kontulainen S,
Kannus P (2002). Effect of 4-min vertical whole body vibration on
muscle performance and body balance: a randomized cross-over
study. Int. J. Sports Med. 23:374–379.
Turbanski S, Haas CT, Schmidtbleicher D, Friedrich A, Duisberg P
(2005). Effects of random whole-body vibration on postural control in
Parkinson's disease. Res. Sports Med. 13:243-256.
Verschueren SM, Roelants M, Delecluse C, Swinnen S,
Vanderschueren D, Boonen SJ (2004). Effect of 6-month whole body
vibrationtraining on hip density,muscle strength, and postural c ontrol
in postmenopausal women: a randomized controlled pilot study. Bone
Miner. Res. 19:352–359.
... The effect of whole body vibration on PD symptoms has been considered since Charcot's 19 th century discovery that PD symptoms subsided during a carriage ride [74]. In two recent reviews, Pinto et al. [75] and Lau et al. [76] reported that vibration at 6-25 Hz or vibrotactile sound at 30 Hz consistently provided the most positive results. ...
... There is a known effect from muscular movement on gamma activity and so potentially might act as a stimulant. Two reviews of whole body vibration research recently show 6 Hz as the most common stimulus with only one using 25 Hz [75,76]. Studies with rTMS on patients with PD [20,60] use a range of frequencies below 25 Hz because of technical limitations and safety considerations, but the mechanism is not generally considered one of excitation and neural driving. ...
Article
This paper addresses the importance of steady state brain oscillation for brain connectivity and cognition. Given that a healthy brain maintains particular levels of oscillatory activity, it argues that disturbances or dysrhythmias of this oscillatory activity can be implicated in common health conditions including Alzheimer’s disease, Parkinson’s Disease, pain, and depression. Literature is reviewed that shows that electric stimulation of the brain can contribute to regulation of neural oscillatory activity and the alleviation of related health conditions. It is then argued that specific frequencies of sound in their vibratory nature can serve as a means to brain stimulation through auditory and vibrotactile means and as such can contribute to regulation of oscillatory activity. The frequencies employed and found effective in electric stimulation are reviewed with the intent of guiding the selection of sound frequencies for vibroacoustic stimulation in the treatment of AD, PD, Pain, and depression.
... 5 Other studies using a technique called Vibroacoustic Therapy (VAT) have shown that vibration at specific frequencies improves certain symptoms. [6][7][8] We must also highlight the work of music therapy at the Neurological Rehabilitation Center for Biomedical Research in Music (CBRM), led by Michael Thaut, which is paving the way for the therapeutic use of sound. 9 Sound is characterized by many different parameters, such as the frequency, duration, and intensity. ...
... A combination of both properties for the experimental stimulation was therefore determined. About 14 Hz was selected as the binaural stimulation because our main target was to decrease the EEG power in the theta band (4)(5)(6)(7)(8). For this reason, we could not use this frequency (it could increase); thus, we acoustically stimulated in a different frequency, specifically at 14 Hz, which falls within the low beta band. ...
Article
Full-text available
We applied rhythmic binaural sound to Parkinson's Disease (PD) patients to investigate its influence on several symptoms of this disease and on Electrophysiology (Electrocardiography and Electroencephalography (EEG)). We conducted a double-blind, randomized controlled study in which rhythmic binaural beats and control were administered over two randomized and counterbalanced sessions (within-subjects repeated-measures design). Patients ([Formula: see text], age [Formula: see text], stage I-III Hoehn & Yahr scale) participated in two sessions of sound stimulation for 10[Formula: see text]min separated by a minimum of 7 days. Data were collected immediately before and after both stimulations with the following results: (1) a decrease in theta activity, (2) a general decrease in Functional Connectivity (FC), and (3) an improvement in working memory performance. However, no significant changes were identified in the gait performance, heart rate or anxiety level of the patients. With regard to the control stimulation, we did not identify significant changes in the variables analyzed. The use of binaural-rhythm stimulation for PD, as designed in this study, seems to be an effective, portable, inexpensive and noninvasive method to modulate brain activity. This influence on brain activity did not induce changes in anxiety or gait parameters; however, it resulted in a normalization of EEG power (altered in PD), normalization of brain FC (also altered in PD) and working memory improvement (a normalizing effect). In summary, we consider that sound, particularly binaural-rhythmic sound, may be a co-assistant tool in the treatment of PD, however more research is needed to consider the use of this type of stimulation as an effective therapy.
... These facts would induce involuntary muscle contractions that would be initiated by sensory receptors and would reduce the recruitment threshold of motor units. In consequence, authors have demonstrated an improvement of the ankle plantar flexor strength and power in an older population [73], the enhancement of the stability in elderly women [73] and improvements in patient with neurological disorders [74][75][76][77][78][79][80][81]. Keeping in the mind the suggested mechanism and the findings reported in the literature, WBVE have been successfully used to treat patients with some diseases related to the impairments involving the central nervous system, as cerebral palsy [75], multiple sclerosis [42], spinal cord injury [76] and stroke [77,78]. ...
... Keeping in the mind the suggested mechanism and the findings reported in the literature, WBVE have been successfully used to treat patients with some diseases related to the impairments involving the central nervous system, as cerebral palsy [75], multiple sclerosis [42], spinal cord injury [76] and stroke [77,78]. Some studies considered also the effects of whole body vibrations on motor symptoms in Parkinson disease [43,74,79,80] and patient with ADHD [56]. Moreover, Regterschot et al, 2014 [57] have investigated acute effects of passive WBV on executive functions in healthy young adults and they concluded that there is a potential of passive WBV as a cognition-enhancing therapy worth further evaluation, especially in persons unable to perform active forms of exercise. ...
Article
Full-text available
Besides the cognitive limitations, individuals with Alzheimer's disease (AD) have posture and gait disturbances and risk of falls. Researchers have reported that appropriate physical activity (PA) can enhance cognitive function and attenuates age-related deterioration of the brain structure. The search of the number of publications (NP) in the database PubMed with the keyword "physical activity" alone and in association with other keywords related to chronic diseases has shown that the scientific interest involving PA and diabetes is the highest and with AD is the smallest. Vibrations generated in oscillating/vibratory platform can produce whole body vibration exercises (WBVE) with relevant improvements in patients. Investigations have introduced WBV training also in patients with neurodegenerative diseases and with attention deficit hyperactivity disorder. The aim of this work is to present the potential importance of the WBVE to AD patients. The NP in the PubMed with the keyword "Whole body vibration" and Alzheimer disease has shown no articles. PA has been considered a non pharmacologic intervention to manage the AD patient Considering that besides the cognitive impairments, AD patients have posture and gait disturbances and risk of falls, it is suggested to include the WBVE in the management of the AD patients. In conclusion, WBVE could be a relevant, viable, safe and inexpensive strategic option of PA to individuals with AD.
... In this respect, whole-body vibration (WBV), i.e., the exposure of the whole body of an individual to vibration, might be interesting. In previous research on clinical samples (Pinto et al. 2010;Santos-Filho et al. 2012 as well as non-clinical samples (Bogaerts et al. 2007;Cardinale and Lim 2003;Cochrane et al. 2008;Lam et al. 2012;Stewart et al. 2005), WBV was shown to have beneficial effects on various physiological measures, including balance, mobility, posture control, muscle strength, oxygen uptake, heart rate, blood pressure and blood flow. Support for the potential value of WBV in improving cognitive performance was provided by studies in mice, demonstrating improved maze learning following the application of WBV (Keijser et al. 2011;Lahr et al. 2009;Timmer et al. 2006; Van der Zee et al. 2010). ...
... WBV treatment was shown to have prolonged effects on cognitive performance and thereby emphasizes its potential for the treatment of patients with ADHD. This is supported by other research reports, discussing the relevance of WBV for the treatment of patients with neurological conditions, including Parkinson's disease, multiple sclerosis or stroke (Pinto et al. 2010;Santos-Filho et al. 2012. Moreover, WBV is easy to apply and may not interfere with conventional treatment methods such as stimulant drug treatment. ...
Article
Full-text available
Adult attention deficit hyperactivity disorder (ADHD) is associated with a variety of cognitive impairments, which were shown to affect academic achievement and quality of life. Current treatment strategies, such as stimulant drug treatment, were demonstrated to effectively improve cognitive functions of patients with ADHD. However, most treatment strategies are associated with a number of disadvantages in a considerable proportion of patients, such as unsatisfactory effects, adverse clinical side effects or high financial costs. In order to address limitations of current treatment strategies, whole-body vibration (WBV) might represent a novel approach to treat cognitive dysfunctions of patients with ADHD. WBV refers to the exposure of the whole body of an individual to vibration and was found to affect physiology and cognition. In the present study, WBV was applied on 10 consecutive days to an adult diagnosed with ADHD. Neuropsychological assessments were performed repeatedly at three different times, i.e., the day before the start of the treatment, on the day following completion of treatment and 14 days after the treatment have been completed (follow-up). An improved neuropsychological test performance following WBV treatment points to the high clinical value of WBV in treating patients with neuropsychological impairments such as ADHD.
... Various forms of exercise training have been found to be well tolerated and to improve symptoms in people with MS [5] [6]. Traditionally , these programs have focused on aerobic exercise and resistance training, but, over the last several years, wholebody vibration (WBV) has become increasingly popular as a method of exercise both for people with neurological disorders [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] and for the general population [19]. WBV is generated when vibrations produced in an oscillating platform are transferred to a human body or parts of it [20]. ...
... In the direct effect, muscles and tendons act spring-like elements that store and release mechanical energy, as the vibrations [20]. These facts would induce involuntary muscle contractions that are initiated by sensory receptors and reduce the recruitment threshold of motor units [18]. In consequence some authors have demonstrated an improvement of the ankle plantar flexor strength and power [23] and the enhancement of the stability [24]. ...
Article
Full-text available
The objective of this work was to investigate the effects of whole-body vibration on people with multiple sclerosis (MS). PubMed, CINAHL and Scopus databases were systematically searched for studies on the use of whole-body vibration (WBV) exercise in people with MS. These searches were supplemented with material identified in the references and in the authors' personal files. A qualitative analysis was performed to summarize the findings. Five studies with a total of seventy-one subjects were identified. All of these studies had small numbers of subjects (3-25), and two of the studies had no control groups. Some investigations have shown significant improvements of the muscle strength, of the functional mobility, and of the timed get up and go test in patients with MS. The number of publications found in the databanks searched is small, and in general, they have limitations in the design of protocols with a weakness to the interpretation of the findings. However, the analysis of the findings in these studies permits to conclude that some papers indicate that WBV exercises could benefit patients with MS. In addition, we suggest further larger scale investigations with controlled parameters and well-designed protocols into the effects of WBV exercises in people with MS.
... The known physical and physiological effects of WBV resemble those of active exercise, and include increased balance, mobility, posture control, oxygen uptake, heart rate, blood pressure, blood flow and muscle strength in healthy adults [2][3][4][5][6]. Beneficial effects of WBV have also been reported in adult samples with neurological conditions such as Parkinson's Disease [7], Alzheimer's Disease [8] and stroke [9]. Studies investigating the effectiveness of WBV for the improvement of physical fitness and the musculoskeletal system in children with physical/muscular disabilities (e.g. ...
Article
Full-text available
Objectives: Whole Body Vibration (WBV) is a passive exercise method known to have beneficial effects on various physical measures. Studies on adults furthermore demonstrated beneficial effects of WBV treatment on cognition (e.g. inhibition). The present study replicated these findings in healthy children and examined acute effects of WBV treatment on inhibition. Methods: Fifty-five healthy children (aged 8-13) participated in this within-subject design study. WBV treatment was applied by having the children sit on a chair mounted to a vibrating platform. After each condition (vibration vs. non-vibration), inhibition was measured by using the Stroop Color-Word Interference Test. Repeated measures analyses were applied in order to explore the effects of WBV treatment on inhibition, and correlations were computed between the treatment effect and participant characteristics in order to explore individual differences in treatment sensitivity. Results: Three-minute WBV treatments had significant beneficial effects on inhibition in this sample of healthy children. Especially the repeated application (three times) of WBV treatment appeared beneficial for cognition. Stronger WBV treatment effects were correlated with higher intelligence and younger age, but not with symptoms of Attention Deficit Hyperactivity Disorder (ADHD). Conclusions: This study demonstrates that especially repeated WBV treatment improves inhibition in healthy children. As this cognitive function is often impaired in children with developmental disorders (e.g. ADHD), future studies should further explore the effects, working mechanism and potential applicability of WBV treatment for this target group.
... Whole-body vibration training (WBV) provides valuable assistance in sports training and physiotherapy. Exercises on a vibration platform have been used in the treatment of patients with non-specific chronic low back pain [1], Parkinson's disease [2], multiple sclerosis [3], hemiplegia [4] and in children with cerebral palsy [5]. Some researchers also report on the use of mechanical vibration for neuromuscular stimulation of weakened pelvic floor muscles (PFM) in women with stress urinary incontinence [6,7]. ...
Article
Full-text available
Background: More and more frequently stress urinary incontinence affects young healthy women. Hence, early implementation of effective preventive strategies in nulliparous continent women is essential, including pelvic floor muscle training. An initial evaluation based on the bioelectrical activity of the pelvic floor muscles (PFM) during whole-body vibration (WBV) would help to devise the best individualized training for prevention of stress urinary incontinence in woman. We hypothesized that synchronous WBV enhances bioelectrical activity of the PFM which depends on vibration frequency and peak-to-peak vibration displacement. Methods: The sample consisted of 36 nulliparous continent women randomly allocated to three comparative groups. Group I and II subjects participated in synchronous whole-body vibrations on a vibration platform; the frequency and peak-to-peak displacement of vibration were set individually for each group. Control participants performed exercises similar to those used in the study groups but without the concurrent application of vibrations. Pelvic floor surface electromyography (sEMG) activity was recorded using a vaginal probe during three experimental trials limited to 30s, 60s and 90s. The mean amplitude and variability of the signal were normalized to the Maximal Voluntary Contraction - MVC. Results: Friedman's two-way ANOVA revealed a statistically significant difference in the mean normalized amplitudes (%MVC) of the sEMG signal from the PFM during 60s- and 90s-trials between the group exposed to high-intensity WBV and control participants (p < 0.05). Longer trial duration was associated with a statistically significant decrease in the variability of sEMG signal amplitude in the study and control groups (p < 0.05). Conclusions: Synchronous high-intensity WBV (40 Hz, 4 mm) of long duration (60s, 90s) significantly enhances the activation of the PFM in young continent women. Prolonged maintenance of a static position significantly decreases the variability of sEMG signal amplitude independent of whole-body vibrations. Single whole-body vibrations in nulliparous continent women does not cause pelvic floor muscle fatigue. Trial registration: The trial was registered in the Australian and New Zealand Clinical Trials Registry (no. ACTRN12615000966594 ); registration date: 15/09/2015.
... Because of its wide range of potential physiological benefits, and because it can be applied in a relatively low-effort, low-impact manner with no complicated technique to learn, some have suggested that WBVT may be of particular benefit to the elderly and special populations characterized by impaired mobility (e.g. patients with stroke, Parkinson's disease, osteoporosis, or arthritis) (Prisby et al., 2008;Cardinale and Wakeling, 2005;Cardinale and Bosco, 2003;Arias et al., 2009;Pinto et al., 2010). ...
Article
Full-text available
Whole body vibration (WBV) can be an important tool to treat patients with osteoarthritis (OA). The purpose of this study was to systematically review published research concerning the use of WBV in people with OA. In PubMed and Scopus, the number of publications (NP) is respectively to the keywords arthrosis, 289,586 and 10,569, osteoarthrosis, 299,158 and 3,952, arthritis, 251,453 and 236,849 and osteoarthritis, 56,323 and 80,008. Putting together the information found in the analyzed 4 papers, the numbers of subjects were ranging from 15 to 52 and frequencies ranging from 24 to 40 Hz. Self-report of the status of disease (WOMAC) was used in 2 papers, while the pain levels were evaluated by the visual analog scale (VAS) in 2 papers. Different tests were used in these studies, as (i) TUG, (ii) step test, (iii) 20-meter walk test, (iv) timed get up and go test (TGUG), (v) chair stand test (CST), (vi) 6-minute walk test (6MWT), (vii) knee muscle strength (extension/flexion) and (viii) proprioception (threshold for detection of passive movement (TDPM) to evaluate the effects promoted by the exercises due to the WBV. In conclusion, these studies indicate that the WBV could bring some benefits to patients with OA.
... However, Parkinson's Disease Quality of Lifequestionnaire (PDQL-BR) can measure the impact of PD on QOL (17). It is worth noting that there are few studies that address the effects of WBV on these patients QOL (18,19) and, to this research, no studies were found, that have quantified the relationship of balance and gait in QOL in individuals with PD, who did not respond to drug treatment, treated by WBV. ...
Article
Full-text available
Introduction Parkinson's disease (PD) is a neurodegenerative disorder, which triggers limitations and disability in people. Therefore, rehabilitation therapy is widely recommended in patients with PD, especially those who do not respond to pharmacological treatment. Objective Evaluate the effect of a protocol of Whole-body Vibration (WBV) in balance, gait and Quality of Life (QOL) of patients with PD, who do not respond to pharmacological treatment. Methods It was performed 12 sessions of a protocol WBV (squat, plantar flexion, isometric contraction of members and single-leg balance), with three sets each, at a vibrating platform (2mm and 35Hz) in 10 PD patients. By the first 3 sessions, patients underwent 20 seconds of exercise and 20 seconds of rest. After the third session, the treatment was 40 seconds of exercise and 20 seconds of rest. The Tinetti Test was applied before and after treatment to assess balance and gait, and the Parkinson's Disease Quality of Life-questionnaire (PDQL-BR), to evaluate the PDQL-BR and its subcategories: Parkinson, Systemic, Social and Emotional. Results Treatment did not significantly change the balance (p = 0.438), QOL issue in Emotional (p = 0.450) and Social (p = 0.171), but improved gait (p = 0.003), the Tinetti (p ≤ 0.001), the quality of life in items Parkinson (p ≤ 0.001), Systemic (p ≤ 0.001) and PDQL-BR (p ≤ 0.001). Conclusions WBV exercises on the vibrating platform, according to the parameters used, showed promising results that encourage its use to improve the clinical conditions related to disorders of gait, balance and QOL in patients with PD.
Article
Full-text available
Aims: A stroke is a neurological disorder and muscle weakness is the most prominent impairment. Whole-body vibration (WBV) is a possible modality of exercise that is useful for improving physical capacity, bone mass, balance, proprioception and the quality of life in healthy subjects and in patients with several diseases and among them, the neurologicaldisorders. Considering the undesirable clinical conditions of the stroke patients, the aim of this review is to discuss about the benefits of the vibrations generated in the oscillating/vibratory platforms to those patients. Methodology: A search was performed in the PubMed using the keywords stroke or "cerebrovascular accident" and "whole body vibration". An isolated search was performed with the term “whole body vibration”. Inclusion and exclusion criteria to select the publications were determined. Results: It is found a limited number of publication involving WBV and the stroke with 16 articles. Of these, 9 publications were rejected for inclusion in this systematic review, due to they did not match the proposed inclusion criteria. Considering the studies that were analysed, about 57% of these have reported an improving in the clinical conditions of the stroke patients with statistical significance. Most probably the reason of the controversial results obtained with WBV findings can be attributed to the diversity of methods to measure the outcomes and the experimental design and the clinical characteristics of the subjects used, as well as the time elapsed post stroke. Conclusion: Putting together the findings and considering the divergence of the results reported, it is suggested that the use of the vibration generated in the vibratory platform could be suitable to try to improve disorders of the stroke patients. However, it is important to consider the limited number of publications available in the PubMed involving searches evaluating the effect of the WBV in stroke patients.
Article
Full-text available
A therapy that slows disease progression is the major unmet need in Parkinson's disease. In this double-blind trial, we examined the possibility that rasagiline has disease-modifying effects in Parkinson's disease. A total of 1176 subjects with untreated Parkinson's disease were randomly assigned to receive rasagiline (at a dose of either 1 mg or 2 mg per day) for 72 weeks (the early-start group) or placebo for 36 weeks followed by rasagiline (at a dose of either 1 mg or 2 mg per day) for 36 weeks (the delayed-start group). To determine a positive result with either dose, the early-start treatment group had to meet each of three hierarchical end points of the primary analysis based on the Unified Parkinson's Disease Rating Scale (UPDRS, a 176-point scale, with higher numbers indicating more severe disease): superiority to placebo in the rate of change in the UPDRS score between weeks 12 and 36, superiority to delayed-start treatment in the change in the score between baseline and week 72, and noninferiority to delayed-start treatment in the rate of change in the score between weeks 48 and 72. Early-start treatment with rasagiline at a dose of 1 mg per day met all end points in the primary analysis: a smaller mean (+/-SE) increase (rate of worsening) in the UPDRS score between weeks 12 and 36 (0.09+/-0.02 points per week in the early-start group vs. 0.14+/-0.01 points per week in the placebo group, P=0.01), less worsening in the score between baseline and week 72 (2.82+/-0.53 points in the early-start group vs. 4.52+/-0.56 points in the delayed-start group, P=0.02), and noninferiority between the two groups with respect to the rate of change in the UPDRS score between weeks 48 and 72 (0.085+/-0.02 points per week in the early-start group vs. 0.085+/-0.02 points per week in the delayed-start group, P<0.001). All three end points were not met with rasagiline at a dose of 2 mg per day, since the change in the UPDRS score between baseline and week 72 was not significantly different in the two groups (3.47+/-0.50 points in the early-start group and 3.11+/-0.50 points in the delayed-start group, P=0.60). Early treatment with rasagiline at a dose of 1 mg per day provided benefits that were consistent with a possible disease-modifying effect, but early treatment with rasagiline at a dose of 2 mg per day did not. Because the two doses were associated with different outcomes, the study results must be interpreted with caution. (ClinicalTrials.gov number, NCT00256204.)
Article
Full-text available
The present article is a preliminary report on the effect of Whole Body Vibration (WBV) on the mobility in long-term immobilized children and adolescents. WBV was applied to 6 children and adolescents (diagnoses: osteogenesis imperfecta, N=4; cerebral palsy, N=1; dysraphic defect of the lumbar spine, N=1) over a time period of 6 months. WBV was applied by a vibrating platform constructed on a tilt-table. The treatment effect was measured by alternations of the tilt-angle of the table and with the "Brief assessment of motor function" (BAMF). All 6 individuals were characterized by an improved mobility, which was documented by an increased tilt-angle or an improved BAMF-score. The authors concluded WBV might be a promising approach to improve mobility in severely motor-impaired children and adolescents. Therefore, the Cologne Standing-and-Walking- Trainer powered by Galileo is a suitable therapeutic device to apply WBV in immobilized children and adolescents.
Article
Locomotion training has been found being effective in various fields of rehabilitation. Besides improving locomotion performance and mobility it became evident in Parkinson's disease (PD) animal experiments that regular locomotion exercises (or forced use strategies) are associated with neuroprotective effects in multiple brain areas. However, numerous neurological patients are unable to do locomotion exercises -by coordinative or energetic reasons -and therefore rehabilitative potentials are reduced. We try to bypass this gap using vibratory stimulations, leading to reflex answers similar to reflex elicitations during human locomotion. Referring to simulations in artificial neural networks and information processing experiments, stimulating signals are superimposed by stochastic components which facilitate nerval threshold crossing and enhance neuromuscular activity. In studies with PD and spinal-cord-injury patients we found that regular stimulation series lead to significantly improved postural control and locomotion abilities. Interestingly, PD patients show also reduced symptoms (e.g. tremor, rigidity) in the upper extremities.
Article
Previous investigations reported enhanced osseous parameters subsequent to administration of whole body vibration (WBV). While the efficacy of WBV continues to be explored, scientific inquiries should consider several key factors. Bone remodeling patterns differ according to age and hormonal status. Therefore, WBV protocols should be designed specifically for the subject population investigated. Further, administration of WBV to individuals at greatest risk for osteoporosis may elicit secondary physiological benefits (e.g., improved balance and mobility). Secondly, there is a paucity of data in the literature regarding the physiological modulation of WBV on other organ systems and tissues. Vibration-induced modulation of systemic hormones may provide a mechanism by which skeletal tissue is enhanced. Lastly, the most appropriate frequencies, durations, and amplitudes of vibration necessary for a beneficial response are unknown, and the type of vibratory signal (e.g., sinusoidal) is often not reported. This review summarizes the physiological responses of several organ systems in an attempt to link the global influence of WBV. Further, we report findings focused on subject populations that may benefit most from such a therapy (i.e., the elderly, postmenopausal women, etc.) in hopes of eliciting multidisciplinary scientific inquiries into this potentially therapeutic aid which presumably has global ramifications.
Article
Therapeutic options for Parkinson's disease (PD) are currently limited to symptomatic agents. Levodopa is the most efficacious treatment; however, higher doses and long-term use are associated with adverse effects such as motor fluctuations and dyskinesia. Early treatment of PD with other agents such as dopamine agonists and monoamine oxidase type B inhibitors can provide symptomatic benefit and delay initiation of levodopa therapy. Early treatment of PD is contingent upon early and accurate diagnosis of the disease, which can be challenging because there are no biomarkers or neuroimaging or other clinical tests available to confirm the diagnosis. PD diagnosis is currently based on the presence or absence of various clinical features and the experience of the treating physician. A definitive diagnosis can be made only after autopsy. Moreover, the signs and symptoms present in early PD can resemble those of a number of other movement disorders, particularly other forms of parkinsonism, such as multiple system atrophy, drug-induced parkinsonism, and vascular parkinsonism, as well as diffuse Lewy body disease and essential tremor. Nevertheless, diagnosis of PD based on clinical features and response to antiparkinsonian medication can be achieved with a fairly high level of accuracy, particularly when made by a physician specializing in movement disorders. This article reviews and summarizes published recommendations for the clinical diagnosis of PD.
Article
Parkinson's disease (PD) is the second most common neurodegenerative disorder, marked by progressive increases in movement-related disability, impaired balance, and nonmotor symptoms. Its prevalence in the United States is expected to double within the next 20 years as the percentage of the elderly in the population grows. Patients with PD have twice the direct medical costs of those without PD, the majority of which occur later in the disease as disability and therapy-related complications increase. Greater awareness of a prodromal/premotor stage of the disease, efforts toward early and accurate diagnosis, and the continuous refinement of treatment paradigms provide an opportunity for discussion on the use of potential disease-modifying agents to slow or halt the progression of motor and nonmotor disability. Such compounds could not only significantly improve patient and caregiver quality of life, but substantially reduce direct and indirect costs. To date, numerous compounds have been evaluated in clinical trials, including coenzyme Q10, creatine, levodopa, pramipexole, rasagiline, ropinirole, and selegiline. None has demonstrated irrefutable and enduring disease-modifying qualities, although the best available clinical evidence appears most promising for rasagiline.